Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?

by Favreau, Mérédis, Vanderkerken, Karin, Elewaut, Dirk, Venken, Koen, Menu, Eline
Published 2016

Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma

by Maes, Ken, Menu, Eline, Van Valckenborgh, Els, Van Riet, Ivan, Vanderkerken, Karin, De Bruyne, Elke
Published 2013

Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models

by Hu, Jinsong, Van Valckenborgh, Els, Menu, Eline, De Bruyne, Elke, Vanderkerken, Karin
Published 2012

Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy

by Dufait, Inès, Van Valckenborgh, Els, Menu, Eline, Escors, David, De Ridder, Mark, Breckpot, Karine
Published 2016

Novel strategies to target the ubiquitin proteasome system in multiple myeloma

by Lub, Susanne, Maes, Ken, Menu, Eline, De Bruyne, Elke, Vanderkerken, Karin, Van Valckenborgh, Els
Published 2015

Histone deacetylase inhibitors in multiple myeloma

by Deleu, Sarah, Menu, Eline, Valckenborgh, Els Van, Van Camp, Ben, Fraczek, Joanna, Vande Broek, Isabelle, Rogiers, Vera, Vanderkerken, Karin
Published 2009

The new anti-actin agent dihydrohalichondramide reveals fenestrae-forming centers in hepatic endothelial cells

by Braet, Filip, Spector, Ilan, Shochet, Nava, Crews, Phillip, Higa, Tatsuo, Menu, Eline, de Zanger, Ronald, Wisse, Eddie
Published 2002

Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma

by Wang, Jinheng, Faict, Sylvia, Maes, Ken, De Bruyne, Elke, Van Valckenborgh, Els, Schots, Rik, Vanderkerken, Karin, Menu, Eline
Published 2016

The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells

by Wang, Jinheng, De Veirman, Kim, De Beule, Nathan, Maes, Ken, De Bruyne, Elke, Van Valckenborgh, Els, Vanderkerken, Karin, Menu, Eline
Published 2015

In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma

by Maes, Ken, De Smedt, Eva, Kassambara, Alboukadel, Hose, Dirk, Seckinger, Anja, Van Valckenborgh, Els, Menu, Eline, Klein, Bernard, Vanderkerken, Karin, Moreaux, Jérôme, De Bruyne, Elke
Published 2014

Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma

by De Veirman, Kim, Rao, Luigia, De Bruyne, Elke, Menu, Eline, Van Valckenborgh, Els, Van Riet, Ivan, Frassanito, Maria Antonia, Di Marzo, Lucia, Vacca, Angelo, Vanderkerken, Karin
Published 2014

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies

by De Veirman, Kim, Van Valckenborgh, Els, Lahmar, Qods, Geeraerts, Xenia, De Bruyne, Elke, Menu, Eline, Van Riet, Ivan, Vanderkerken, Karin, Van Ginderachter, Jo A.
Published 2014

The role of DNA damage and repair in decitabine-mediated apoptosis in multiple myeloma

by Maes, Ken, Smedt, Eva De, Lemaire, Miguel, Raeve, Hendrik De, Menu, Eline, Van Valckenborgh, Els, McClue, Steve, Vanderkerken, Karin, De Bruyne, Elke
Published 2014

Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model

by Nur, Haneen, Fostier, Karel, Aspeslagh, Sandrine, Renmans, Wim, Bertrand, Elisabeth, Leleu, Xavier, Favreau, Mérédis, Breckpot, Karine, Schots, Rik, De Waele, Marc, Van Valckenborgh, Els, De Bruyne, Elke, Facon, Thierry, Elewaut, Dirk, Vanderkerken, Karin, Menu, Eline
Published 2013

SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma

by Heusschen, Roy, Muller, Joséphine, Binsfeld, Marilène, Marty, Caroline, Plougonven, Erwan, Dubois, Sophie, Mahli, Nadia, Moermans, Karen, Carmeliet, Geert, Léonard, Angélique, Baron, Frédéric, Beguin, Yves, Menu, Eline, Cohen-Solal, Martine, Caers, Jo
Published 2016

Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells

by Lub, Susanne, Maes, Anke, Maes, Ken, De Veirman, Kim, De Bruyne, Elke, Menu, Eline, Fostier, Karel, Kassambara, Alboukadel, Moreaux, Jérôme, Hose, Dirk, Leleu, Xavier, King, Randall W., Vanderkerken, Karin, Van Valckenborgh, Els
Published 2015

Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells

by De Veirman, Kim, Van Ginderachter, Jo A., Lub, Susanne, De Beule, Nathan, Thielemans, Kris, Bautmans, Ivan, Oyajobi, Babatunde O., De Bruyne, Elke, Menu, Eline, Lemaire, Miguel, Van Riet, Ivan, Vanderkerken, Karin, Van Valckenborgh, Els
Published 2015

The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic

by Bieghs, Liesbeth, Lub, Susanne, Fostier, Karel, Maes, Ken, Van Valckenborgh, Els, Menu, Eline, Johnsen, Hans E., Overgaard, Michael T., Larsson, Olle, Axelson, Magnus, Nyegaard, Mette, Schots, Rik, Jernberg-Wiklund, Helena, Vanderkerken, Karin, De Bruyne, Elke
Published 2014